COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,398 Articles (22,816 medRxiv, 8,582 bioRxiv)

Most recent first Previous |  Page 1064: Articles 10631-10640  | Next

Effectiveness of different booster regimens for preventing infection and adverse outcomes in Puerto Rico
Irizarry, R. A., Robles Fontan, M. M.
10.1101/2021.12.19.21268070 — Posted: 2021-12-21
Factors associated with COVID-19 vaccine hesitancy in Senegal: a mixed study
Ba, M. F., Faye, A., Kane, B., Diallo, A. I., Junot, A., Gaye, I., Bonnet, E., Ridde, V.
10.1101/2021.12.20.21267724 — Posted: 2021-12-21
The Place of Fluvoxamine in the Treatment of Non-critically ill Patients with COVID-19: A Living Systematic Review and Meta-analysis
Kacimi, S. E. O., Greca, E., Haireche, M. A., Sallam ElHawary, A., Ould Setti, M., Caruana, R., Rizwan, S., Benyettou, H., Yasir Essar, M., Shah, J., Ghozy, S.
10.1101/2021.12.19.21268044 — Posted: 2021-12-21
Evaluation of the Roche SARS-CoV-2 Rapid Antibody Test in samples from vaccinated individuals
Urlaub, E., Hayer, J.
10.1101/2021.12.17.21267927 — Posted: 2021-12-21
RESISTANCE CONFERRING MUTATIONS IN SARS-CoV-2 DELTA FOLLOWING SOTROVIMAB INFUSION
Rockett, R. J., Basile, K., Maddocks, S., Fong, W., Agius, J. E., Johnson-Mackinnon, J., Arnott, A., Chandra, S., Gall, M., Draper, J. L., Martinez, E., Sim, E. M., Lee, C., Ngo, C., Ramsperger, M., Ginn, A. N., Wang, Q., Fennell, M., Ko, D., Lim, L., Gilroy, N., Sullivan, M. V., Chen, S. C.-A., Kok, J., Dwyer, D. E., Sintchenko, V. L.
10.1101/2021.12.18.21267628 — Posted: 2021-12-21
The role of airborne transmission in a large single source outbreak of SARS-CoV-2 in a Belgian nursing home in 2020
Vuylsteke, B., Cuypers, L., Baele, G., Stranger, M., Lima Paralovo, S., Andre, E., Dirks, J., Maes, P., Laga, M.
10.1101/2021.12.17.21267362 — Posted: 2021-12-21
Outpatient therapies for COVID-19: How do we choose?
Lee, T. C., Morris, A. M., Grover, S. A., Murthy, S., McDonald, E. G.
10.1101/2021.12.17.21268007 — Posted: 2021-12-21
Real-world clinical outcomes of treatment with casirivimab-imdevimab among patients with mild-to-moderate coronavirus disease 2019 during the Delta variant pandemic
Suzuki, Y., Shibata, Y., Minemura, H., Nikaido, T., Tanino, Y., Fukuhara, A., Kanno, R., Saito, H., Suzuki, S., Ishii, T., Inokoshi, Y., Sando, E., Sakuma, H., Kobayashi, T., Kume, H., Kamimoto, M., Aoki, H., Takama, A., Kamiyama, T., Nakayama, M., Saito, K., Tanigawa, K., Sato, M., Kanbe, T., Kanzaki, N., Azuma, T., Sakamoto, K., Nakamura, Y., Otani, H., Waragai, M., Maeda, S., Ishida, T., Sugino, K., Tsukada, Y., Yamada, R., Sato, R., Omuna, T., Tomita, H., Saito, M., Watanabe, N., Rikimaru, M., Kawamata, T., Umeda, T., Morimoto, J., Togawa, R., Sato, Y., Saito, J., Kanazawa, K., Iseki, K.
10.1101/2021.12.19.21268078 — Posted: 2021-12-21
Therapies for Long COVID in non-hospitalised individuals - from symptoms, patient-reported outcomes, and immunology to targeted therapies (The TLC Study): Study protocol
Haroon, S., Nirantharakumar, K., Hughes, S., Subramanian, A., Aiyegbusi, O. L., Davies, E. H., Myles, P., Williams, T., Turner, G., Chandan, J. S., McMullan, C., Lord, J., Wraith, D., McGee, K., Denniston, A., Taverner, T., Jackson, L., Sapey, E., Gkoutos, G., Gokhale, K., Leggett, E., Iles, C., Frost, C., McNamara, G., Bamford, A., Marshall, T., Zemedikun, D., Price, G., Marwaha, S., Simms-Williams, N., Brown, K., Walker, A., Jones, K., Matthews, K., Camaradou, J., Saint-Cricq, M., Kumar, S., Alder, Y., Stanton, D., Agyen, L., Baber, M., Blaize, H., Calvert, M.
10.1101/2021.12.20.21268098 — Posted: 2021-12-21
Time Between Viral Loads for People with HIV during the COVID-19 Pandemic
El-Nahal, W. G., Shen, N. M., Keruly, J. C., Jones, J. L., Fojo, A. T., Manabe, Y. C., Moore, R. D., Gebo, K. A., Chander, G., Lesko, C. R.
10.1101/2021.12.19.21268052 — Posted: 2021-12-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).